Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) Enterprise Value (2023 - 2025)

Bioharvest Sciences has reported Enterprise Value over the past 3 years, most recently at -$23.0 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 863.39% year-over-year to -$23.0 million; the TTM value through Dec 2025 reached -$23.0 million, down 863.39%, while the annual FY2025 figure was -$23.0 million, 863.39% down from the prior year.
  • Enterprise Value was -$23.0 million for Q4 2025 at Bioharvest Sciences, down from -$2.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$1.7 million in Q2 2023 and bottomed at -$23.0 million in Q4 2025.
  • The 3-year median for Enterprise Value is -$3.4 million (2025), against an average of -$5.3 million.
  • Year-over-year, Enterprise Value soared 55.37% in 2024 and then tumbled 863.39% in 2025.
  • Over 3 years, Enterprise Value stood at -$5.4 million in 2023, then soared by 55.37% to -$2.4 million in 2024, then tumbled by 863.39% to -$23.0 million in 2025.
  • The last three reported values for Enterprise Value were -$23.0 million (Q4 2025), -$2.4 million (Q3 2025), and -$2.4 million (Q2 2025) per Business Quant data.